Thromboinflammation is a key driver for the progression of cardiovascular diseases, leading to blood vessel occlusions and organ damage.
APAC Therapeutic
Aplagon’s therapeutic asset is known as APAC, a unique vascular injury targeting, triple action antiplatelet (AP), anticoagulant (AC) and anti-inflammatory molecule, designed to combat a wide range of thromboinflammatory diseases.
